Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Non Corticosteroid Anti-inflammatory Eyedrops Market by Type (Ocufen, Mugabe, Diclofenac, Others), By Application (Adult, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Non Corticosteroid Anti-inflammatory Eyedrops Market by Type (Ocufen, Mugabe, Diclofenac, Others), By Application (Adult, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130254 3300 Pharma & Healthcare 377 237 Pages 4.7 (46)
                                          

The global non-corticosteroid anti-inflammatory eyedrops market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 1.2 billion by 2030. The market is driven by factors such as increasing prevalence of ocular inflammation and rising demand for non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of ocular inflammation. Non-steroidal anti-inflammatory drugs are used in the treatment of various eye conditions such as allergic conjunctivitis, vernal keratoconjunctivitis, and dry eye syndrome. These drugs are also used in the management of postoperative pain following cataract surgery or corneal refractive surgery procedures. Non-steroidal anti inflammatory eyedrops are available in different formulations such as Ocufen, Mugabe, Diclofenac and others which have been approved by FDA for use in adults and children with ocular inflammation symptoms.

Some Of The Growth Factors Of This Market:

  1. The increasing prevalence of allergic conjunctivitis and dry eye syndrome is expected to drive the demand for non-corticosteroid anti-inflammatory eyedrops.
  2. The increasing number of people suffering from chronic eye diseases such as glaucoma, cataract, and age-related macular degeneration is also expected to drive the demand for non-corticosteroid anti-inflammatory eyedrops.
  3. The growing awareness about the side effects associated with corticosteroids is also expected to fuel the growth of this market in near future.
  4. Increasing incidence rates of ocular surface disorders such as dry eye syndrome and allergic conjunctivitis are anticipated to boost the demand for non-corticosteroid anti inflammatory eyedrops.
  5. Increasing geriatric population base coupled with rising incidence rates of chronic eye diseases are anticipated to fuel the growth of this market.

Industry Growth Insights published a new data on “Non Corticosteroid Anti-inflammatory Eyedrops Market”. The research report is titled “Non Corticosteroid Anti-inflammatory Eyedrops Market research by Types (Ocufen, Mugabe, Diclofenac, Others), By Applications (Adult, Children), By Players/Companies Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Non Corticosteroid Anti-inflammatory Eyedrops Market Research Report

By Type

Ocufen, Mugabe, Diclofenac, Others

By Application

Adult, Children

By Companies

Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

237

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Non Corticosteroid Anti-inflammatory Eyedrops Industry Outlook


Global Non Corticosteroid Anti-inflammatory Eyedrops Market Report Segments:

The global Non Corticosteroid Anti-inflammatory Eyedrops market is segmented on the basis of:

Types

Ocufen, Mugabe, Diclofenac, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Adult, Children

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Novartis AG
  2. Allergan, Inc.
  3. Meda Pharmaceuticals Inc
  4. Bausch & Lomb Inc
  5. Cigna
  6. Similasan Corporation
  7. Visine
  8. Alcon
  9. Viva Opti-Free
  10. Bausch & Lomb
  11. Systane
  12. Rite Aid
  13. Walgreens
  14. Staples
  15. Clear eyes

Global Non Corticosteroid Anti-inflammatory Eyedrops Market Overview


Highlights of The Non Corticosteroid Anti-inflammatory Eyedrops Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Ocufen
    2. Mugabe
    3. Diclofenac
    4. Others
  1. By Application:

    1. Adult
    2. Children
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Non Corticosteroid Anti-inflammatory Eyedrops Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Non Corticosteroid Anti-inflammatory Eyedrops Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Non Corticosteroid Anti-inflammatory Eyedrops Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Non Corticosteroid Anti-inflammatory Eyedrops Market - Supply Chain
   4.5. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Forecast
      4.5.1. Non Corticosteroid Anti-inflammatory Eyedrops Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Non Corticosteroid Anti-inflammatory Eyedrops Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Absolute $ Opportunity

5. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
      5.3.1. Ocufen
      5.3.2. Mugabe
      5.3.3. Diclofenac
      5.3.4. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
      6.3.1. Adult
      6.3.2. Children
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Non Corticosteroid Anti-inflammatory Eyedrops Demand Share Forecast, 2019-2029

9. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
      9.4.1. Adult
      9.4.2. Children
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
      9.7.1. Ocufen
      9.7.2. Mugabe
      9.7.3. Diclofenac
      9.7.4. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Non Corticosteroid Anti-inflammatory Eyedrops Demand Share Forecast, 2019-2029

10. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
      10.4.1. Adult
      10.4.2. Children
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
      10.7.1. Ocufen
      10.7.2. Mugabe
      10.7.3. Diclofenac
      10.7.4. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Demand Share Forecast, 2019-2029

11. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
      11.4.1. Adult
      11.4.2. Children
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type      11.7.1. Ocufen
      11.7.2. Mugabe
      11.7.3. Diclofenac
      11.7.4. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Non Corticosteroid Anti-inflammatory Eyedrops Demand Share, 2019-2029

12. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
      12.4.1. Adult
      12.4.2. Children
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
      12.7.1. Ocufen
      12.7.2. Mugabe
      12.7.3. Diclofenac
      12.7.4. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Demand Share, 2019-2029

13. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
      13.4.1. Adult
      13.4.2. Children
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
      13.7.1. Ocufen
      13.7.2. Mugabe
      13.7.3. Diclofenac
      13.7.4. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Non Corticosteroid Anti-inflammatory Eyedrops Market: Market Share Analysis
   14.2. Non Corticosteroid Anti-inflammatory Eyedrops Distributors and Customers
   14.3. Non Corticosteroid Anti-inflammatory Eyedrops Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Novartis AG
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Allergan, Inc.
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Meda Pharmaceuticals Inc
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Bausch & Lomb Inc
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Cigna
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Similasan Corporation
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Visine
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Alcon
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Viva Opti-Free
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Bausch & Lomb
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Systane
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Rite Aid
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Walgreens
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Staples
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Clear eyes
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us